James Investment Research Inc. cut its stake in CBRE Group, Inc. (NYSE:CBRE – Free Report) by 1.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 33,853 shares of the financial services provider’s stock after selling 666 shares during the quarter. James Investment Research Inc.’s holdings in CBRE Group were worth $4,214,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in CBRE. Swedbank AB purchased a new position in CBRE Group during the first quarter worth about $162,576,000. Eminence Capital LP lifted its stake in CBRE Group by 42.6% during the second quarter. Eminence Capital LP now owns 1,518,203 shares of the financial services provider’s stock worth $135,287,000 after purchasing an additional 453,406 shares during the last quarter. Maverick Capital Ltd. bought a new stake in CBRE Group during the second quarter worth about $36,820,000. Delta Global Management LP lifted its stake in CBRE Group by 266.2% during the first quarter. Delta Global Management LP now owns 543,780 shares of the financial services provider’s stock worth $52,877,000 after purchasing an additional 395,297 shares during the last quarter. Finally, Nordea Investment Management AB lifted its stake in CBRE Group by 1,730.4% during the first quarter. Nordea Investment Management AB now owns 394,418 shares of the financial services provider’s stock worth $38,550,000 after purchasing an additional 372,870 shares during the last quarter. 98.41% of the stock is currently owned by hedge funds and other institutional investors.
CBRE Group Price Performance
Shares of CBRE Group stock opened at $130.18 on Friday. CBRE Group, Inc. has a one year low of $71.09 and a one year high of $136.06. The stock’s fifty day moving average is $121.64 and its 200 day moving average is $103.64. The stock has a market cap of $39.84 billion, a P/E ratio of 41.86 and a beta of 1.40. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.13 and a current ratio of 1.13.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on CBRE shares. Raymond James boosted their target price on CBRE Group from $122.00 to $124.00 and gave the company a “strong-buy” rating in a research note on Thursday, July 25th. Morgan Stanley initiated coverage on CBRE Group in a report on Thursday, July 25th. They set an “equal weight” rating and a $105.00 target price on the stock. Evercore ISI upped their target price on CBRE Group from $123.00 to $132.00 and gave the stock an “outperform” rating in a report on Friday, October 4th. Wolfe Research upgraded CBRE Group to a “strong-buy” rating in a research note on Friday, August 16th. Finally, Keefe, Bruyette & Woods upped their price target on CBRE Group from $125.00 to $138.00 and gave the stock a “market perform” rating in a research note on Tuesday. Five research analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, CBRE Group presently has an average rating of “Moderate Buy” and a consensus target price of $116.83.
Check Out Our Latest Stock Report on CBRE Group
Insiders Place Their Bets
In other news, Director Christopher T. Jenny sold 10,847 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $112.00, for a total transaction of $1,214,864.00. Following the completion of the transaction, the director now owns 51,244 shares in the company, valued at $5,739,328. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Christopher T. Jenny sold 10,847 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $112.00, for a total value of $1,214,864.00. Following the completion of the transaction, the director now owns 51,244 shares of the company’s stock, valued at approximately $5,739,328. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Daniel G. Queenan sold 10,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $114.67, for a total transaction of $1,146,700.00. Following the completion of the transaction, the chief executive officer now directly owns 217,094 shares of the company’s stock, valued at approximately $24,894,168.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,232 shares of company stock worth $2,839,047. Corporate insiders own 0.54% of the company’s stock.
CBRE Group Company Profile
CBRE Group, Inc operates as a commercial real estate services and investment company in the United States, the United Kingdom, and internationally. The Advisory Services segment offers strategic advice and execution to owners, investors, and occupiers of real estate in connection with leasing of offices, and industrial and retail space; clients fully integrated property sales services under the CBRE Capital Markets brand; clients commercial mortgage and structured financing services; originates and sells commercial mortgage loans; property management services, such as marketing, building engineering, accounting, and financial services on a contractual basis for owners of and investors in office, industrial, and retail properties; and valuation services that include market value appraisals, litigation support, discounted cash flow analyses, and feasibility studies, as well as consulting services, such as property condition reports, hotel advisory, and environmental consulting.
Further Reading
- Five stocks we like better than CBRE Group
- Stock Analyst Ratings and Canadian Analyst Ratings
- Battle of the Retailers: Who Comes Out on Top?
- Short Selling: How to Short a Stock
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding CBRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CBRE Group, Inc. (NYSE:CBRE – Free Report).
Receive News & Ratings for CBRE Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBRE Group and related companies with MarketBeat.com's FREE daily email newsletter.